AIM IMMUNOTECH INC. Proceeds from Sale and Maturity of Debt Securities, Available-for-sale
AIM IMMUNOTECH INC. (AIM) reported Proceeds from Sale and Maturity of Debt Securities, Available-for-sale of $6.84 million for the 12-month period ending 2015-12-31, per its 10-K filed 2016-03-29.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities · last filed 2016-03-29
- AIM IMMUNOTECH INC. proceeds from sale and maturity of debt securities, available-for-sale for fiscal 2015 was $6.84M, a 107.71% increase from fiscal 2014.
- AIM IMMUNOTECH INC. proceeds from sale and maturity of debt securities, available-for-sale for fiscal 2014 was $3.29M, a 86.01% decline from fiscal 2013.
- AIM IMMUNOTECH INC. proceeds from sale and maturity of debt securities, available-for-sale for fiscal 2013 was $23.55M.
| Period end | Proceeds from Sale and Maturity of Debt Securities, Available-for-sale 12 month |
|---|---|
| 2015-12-31 | $6.84M 10-K · filed 2016-03-29 |
| 2014-12-31 | $3.29M 10-K · filed 2016-03-29 |
| 2013-12-31 | $23.55M 10-K · filed 2016-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |